Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Mar 16, 2025; 17(3): 97016
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.97016
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.97016
Table 1 Statistical analysis using the Pearson correlation test
Category | Measurement | Crohn’s disease (n = 67) | Ulcerative colitis (n = 34) |
Baseline characteristics | Gender | Male: 45%; Female: 55% | Male: 50%; Female: 50% |
Age (years), mean ± SD | 35.4 ± 12.7 | 40.2 ± 14.5 | |
BMI (kg/m²), mean ± SD | 23.1 ± 3.5 | 24.0 ± 4.1 | |
Disease duration, median (IQR), year | 7 (3-12) | 5 (2-10) | |
Smoking status | Smokers: 30%; Non-smokers: 70% | Smokers: 20%; Non-smokers: 80% | |
Medication use | Biologics: 60%; Immunomodulators: 40% | Biologics: 50%; Immunomodulators: 50% | |
Disease location | Ileum: 45%; Colon: 35%; Ileocolon: 20% | Left-sided: 60%; Pancolitis: 40% | |
IUS and endoscopy inflammation signs | IUS inflammation vs endoscopic inflammation | P: 0.004; R: 0.851 (0.70-0.94); N: 56, 83% | P: 0.007; R: 0.842 (0.78-0.96); N: 24, 72% |
Limberg endoscopic score > 2 and deep ulcers | P: 0.079 | P: 0.089 | |
IUS inflammation and clinical scores | Intestinal BWT vs HBI score > 4 (CD). Intestinal BWT vs Mayo score > 7 (UC) | P: 0.6; R: 0.18 (0.02-0.35); N: 56, 83% | P: 0.27; R: 0.230 (0.117-0.527); N: 23, 70% |
IUS and endoscopic remission | Endoscopic remission vs IUS remission | P: 0.03; R: 0.656 (0.47-0.87); N: 9, 13% | P: 0.04; R: 0.62 (0.44-0.71); N: 6, 19% |
IUS and endoscopic location | Same location in endoscopy and IUS | P: 0.04; R: 0.53 (0.31-0.65); N: 48, 71% | P: 0.035; R: 0.647 (0.434-0.772); N: 25, 76% |
Collection in IUS and CT scan | Collection in IUS vs collection in CT scan | P: < 0.01; R: 0.835 (0.699-0.969); N: 6, 9% | P: < 0.01; R: 0.835 (0.699-0.969); N: 10, 14% |
Bowel thickness and endoscopic scores | BWT > 7 mm vs CDEIS > 15 (CD). BWT > 7 mm vs UCEIS > 6 (UC) | P: 0.053; R: 0.452 (0.2-0.61); N: 22, 47% | P: 0.008; R: 0.87 (0.759-0.94); N: 16, 47% |
Inflammatory activity in IUS and histology | Inflammatory activity in IUS vs histology | P: 0.012; R: 0.72 (0.68-0.84); N: 53, 87% | P: 0.21; R: 0.25 (0.13-0.317); N: 24, 72% |
Detailed IUS and endoscopic findings | Bowel wall thickness, mean ± SD | 5.4 ± 1.2 mm | 4.8 ± 1.1 mm |
Vascularity (Doppler) | Increased: 65%; Normal: 35% | Increased: 55%; Normal: 45% | |
Mucosal ulceration | Present: 40%; Absent: 60% | Present: 35%; Absent: 65% | |
Stratification loss | Present: 30%; Absent: 70% | Present: 25%; Absent: 75% | |
Fistulas/abscesses | Present: 15%; Absent: 85% | Present: 10%; Absent: 90% |
- Citation: Abid H, Cherkaoui H, Benahsine F, Lamine A, Lahlali M, Chaouche I, Bartal F, Lahmidani N, Elmekkaoui A, Benajah DA, Abkari M, Ibrahimi SA, Elghazi K, Maaroufi M, Elyousfi M. Non-invasive monitoring of inflammatory bowel disease using intestinal ultrasound. World J Gastrointest Endosc 2025; 17(3): 97016
- URL: https://www.wjgnet.com/1948-5190/full/v17/i3/97016.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i3.97016